Short answer
CASTLE BIOSCIENCES INC (CSTL) filed an 8-K current report with the SEC on May 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q1 2026 results for quarter ended March 31, 2026 released May 6, 2026.
CASTLE BIOSCIENCES INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results for quarter ended March 31, 2026 released May 6, 2026
- Detailed financial results and management commentary contained in Exhibit 99.1
- Exhibit 99.1 not deemed filed under Exchange Act Section 18 unless specifically incorporated by reference
Item 7.01 · Regulation FD Disclosure
- Castle Biosciences released investor presentation materials on May 6, 2026
- Presentation may guide management discussions in future investor meetings
- Market relevance depends on substantive operating or financial information in Exhibit 99.2
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CASTLE BIOSCIENCES INC 8-K filings
Get the next CSTL 8-K as it lands
Follow CSTL for push alerts, or ask the research agent what this filing means.